genomic-valley-biotech-ltd
Home
Genomic Valley Biotech Ltd
null Share Price
BSE:
NSE:
null Share Price
BSE:
NSE:
Miscellaneous
Small Cap
₹-
0 (0%)
Market Cap
₹28.51 Cr
PE Ratio
112.47
Genomic Valley Biotech Ltd Performance
▲
▲
▲
▲
Genomic Valley Biotech Ltd Fundamentals
Genomic Valley Biotech Ltd Delivery and Volume
About Genomic Valley Biotech Ltd
Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market n
| Name | Designation |
|---|---|
| Yogesh Agrawal | Chairman & Managing Director |
| Parul Agrawal | Director |
| Gupta Pradeep | Independent Director |
| Jyoti Bansal | Additional Director |
| praveen Kumar Mishra | Additional Director |
| Ashok Kumar Khattar | Additional Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Genomic Valley Biotech Ltd FAQs
How do I Buy Genomic Valley Biotech Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Genomic Valley Biotech Ltd shares in BlinkX.
What is the Share Price of Genomic Valley Biotech Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Genomic Valley Biotech Ltd's share price is ₹93.35 as of 2024-12-15.
What is the PE ratio of Genomic Valley Biotech Ltd?
Genomic Valley Biotech Ltd's P/E ratio is 112.47 times as of 2024-12-15.
What is the PB ratio of Genomic Valley Biotech Ltd?
Genomic Valley Biotech Ltd's most recent financial reports indicate a price-to-book ratio of 7.47, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Genomic Valley Biotech Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Genomic Valley Biotech Ltd's market capitalization is ₹28.51 Cr as on 2024-12-15.
What is the ROE of Genomic Valley Biotech Ltd?
The current financial records of Genomic Valley Biotech Ltd show a 0.57% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Genomic Valley Biotech Ltd?
According to Genomic Valley Biotech Ltd's most recent financial filings, the company has a total asset value of ₹2.91, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Genomic Valley Biotech Ltd?
The 52-week high/low price of a Genomic Valley Biotech Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Genomic Valley Biotech Ltd's 52-week high and low as of 2024-12-15 are ₹98.3 and ₹91.25, respectively.
